Breaking News
Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Pfizer historical data, for real-time data please try another search
422.6 0.0    0.00%
28/02 - Closed. Currency in SEK ( Disclaimer )
Type:  Equity
Market:  Sweden
ISIN:  US7170811035 
S/N:  6633982
  • Volume: 0
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 417.4 - 425.0
Pfizer 422.6 0.0 0.00%

PFE Balance Sheet

 
Featured here, the Balance Sheet for Pfizer Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
02/07
2023
02/04
2022
31/12
2022
02/10
Total Current Assets 73347 50078 51259 70403
Cash and Short Term Investments 44785 19972 22732 36132
Cash - - - -
Cash & Equivalents 2632 2166 416 1298
Short Term Investments 42153 17806 22316 34825
Total Receivables, Net 13425 15445 14529 18620
Accounts Receivables - Trade, Net 10231 12305 10952 16076
Total Inventory 10310 9541 8981 9513
Prepaid Expenses - - - -
Other Current Assets, Total 4827 5120 5017 6138
Total Assets 220168 195617 197205 195350
Property/Plant/Equipment, Total - Net 17488 17052 19276 15441
Property/Plant/Equipment, Total - Gross 33042 32566 34450 30372
Accumulated Depreciation, Total -15554 -15514 -15174 -14931
Goodwill, Net 51572 51476 51375 49441
Intangibles, Net 41406 42002 43370 28151
Long Term Investments 14945 14628 14926 13888
Note Receivable - Long Term 3194 3140 3577 2544
Other Long Term Assets, Total 13149 13079 12199 10890
Other Assets, Total 52126 24324 26585 39001
Total Current Liabilities 34647 36562 42138 44314
Accounts Payable 6081 6123 6809 6267
Payable/Accrued - - - -
Accrued Expenses 7252 7541 8316 7261
Notes Payable/Short Term Debt 420 621 385 1474
Current Port. of LT Debt/Capital Leases 3580 3567 3190 2566
Other Current liabilities, Total 17314 18710 23438 26746
Total Liabilities 120875 94381 101288 102460
Total Long Term Debt 61674 31978 33205 32959
Long Term Debt 61674 31978 33205 32959
Capital Lease Obligations - - - -
Deferred Income Tax 1232 1067 1023 616
Minority Interest 274 266 256 259
Other Liabilities, Total 22628 23887 24281 22838
Total Equity 99293 101236 95917 92890
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 478 478 476 476
Additional Paid-In Capital 92329 92153 91802 91359
Retained Earnings (Accumulated Deficit) 128796 131102 125656 122967
Treasury Stock - Common -114482 -114473 -113969 -113945
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -7828 -8024 -8048 -7967
Total Liabilities & Shareholders' Equity 220168 195617 197205 195350
Total Common Shares Outstanding 5645 5645 5616 5612
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
George Galloway
George Galloway Sep 22, 2023 1:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sad company with zero leadership and zero vision.
damian del
mudlog79 Sep 22, 2023 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dump this trash
Hisham Chehab
Hisham Chehab Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can anyone provide a good vision for this stock plz.
Thị Mỹ Thuận Trần
Thị Mỹ Thuận Trần Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30 $ soon
Crim Jamer
Crim Jamer Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just believe what you see. I bought calls on last friday, they are almost total loss now.
Jay Clerk
Jay Clerk Sep 21, 2023 2:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If you get your bews from the mainstream then your bound to ve a victim , you just wont get it . Been shorting since 52$ havent let up once its going to 20s! This company is run by satan!
Jay Clerk
Jay Clerk Sep 18, 2023 6:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Poopiest stock that ever circled the toilet
George Galloway
George Galloway Sep 13, 2023 1:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
change at CEO is very much needed
liebe dich ich
liebe dich ich Sep 13, 2023 6:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wtf Pfizer stock? CEO should retire and get down his salary!
Jay Clerk
Jay Clerk Sep 12, 2023 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nobody with common sense will be getting another death jabbed. You have to be crazy to put that poisen in your viens
aux fipe
aux fipe Sep 12, 2023 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hooked on Phonics is a great tool.
Anand Guru
Anand Guru Sep 11, 2023 10:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Read as FDA approval
Anand Guru
Anand Guru Sep 11, 2023 10:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer gets approval from NDA For 2023 -2024
Vlas Dacian
Vlas Dacian Sep 11, 2023 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30-31$ buy area
Jay Clerk
Jay Clerk Sep 11, 2023 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Im thinking more like17$
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email